glp-1 obesity drug news today september 15 2025 The FDA approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Lilly and Novo finalize GLP-1
Description
20 TECOS (2015) did not show an increased risk of HF in patients taking sitagliptin for treatment of type 2 diabetes
With my own experience in my practice and science backing it, I felt comfortable enough to start prescribing these medications myself to my patients who arent able to tolerate CPAP, Izzo says
Common injection sites include the lower abdomen or thigh
Hawkins, J., Cifuentes, M., Pleshko, N
and Cytochem
2008;3(Suppl 2):S2937
